BENZIMIDAZOLONE DERIVED INHIBITORS OF BCL6

Number of patents in Portfolio can not be more than 2000

United States of America

APP PUB NO 20240417388A1
SERIAL NO

18798355

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to compounds of Formula I that function as inhibitors of BCL6 (B-cell lymphoma 6) activity:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CANCER RESEARCH TECH LTDNot Provided

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bellenie, Benjamin Richard London, GB 11 17
Carter, Michael K London, GB 6 95
Cheung, Kwai Ming Jack London, GB 5 9
Davis, Owen Alexander London, GB 6 9
Hoelder, Swen London, GB 26 92
Innocenti, Paolo London, GB 11 55
Lloyd, Matthew Garth London, GB 5 9
Rodriguez, Ana Varela London, GB 2 0
Woodward, Hannah London, GB 11 55

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation